Abstract
As public health concerns have changed, regulatory expectations for assessing abuse liability of new central nervous system (CNS) drugs have increased. All CNS-active drugs with any properties indicating stimulant, depressant, hallucinogenic, or mood-elevating effects will require an evaluation of abuse liability. Abuse liability assessment involves the collection, analysis, and interpretation of data on chemistry and tampering, animal behavioral pharmacology, clinical trial adverse events (AEs), diversion and overdose, and potentially reinforcing (subjective) effects in recreational drug users.
References
Dec 1, 1991·British Journal of Addiction·J Camí
May 22, 2003·Drug and Alcohol Dependence·Robert L Balster, George E Bigelow
May 22, 2003·Drug and Alcohol Dependence·Roland R GriffithsNancy A Ator
May 22, 2003·Drug and Alcohol Dependence·Nancy A Ator, Roland R Griffiths
May 22, 2003·Drug and Alcohol Dependence·Robert S MansbachSidney H Schnoll
May 22, 2003·Drug and Alcohol Dependence·Kathleen T BradyJoseph V Brady
Feb 25, 2006·Biological Psychology·David H EpsteinDonald R Jasinski
Mar 24, 2006·Drug and Alcohol Dependence·Shelley McColl, Edward M Sellers
Mar 28, 2006·Drug and Alcohol Dependence
Apr 4, 2006·Drug and Alcohol Dependence·Charles GrudzinskasC Wright
Sep 14, 2006·Current Psychiatry Reports·Robert F FormanA Thomas McLellan
Citations
Apr 18, 2009·Harvard Review of Psychiatry·Helen C Fox, Rajita Sinha
Dec 5, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lawrence P CarterDorothy K Hatsukami
Feb 27, 2013·Journal of Biopharmaceutical Statistics·Ling Chen, Katherine R Bonson
Aug 29, 2014·Human Psychopharmacology·Justin C StricklandWilliam W Stoops
Mar 29, 2014·Drug Testing and Analysis·Hamilton Morris, Jason Wallach
Nov 19, 2013·Journal of Clinical Pharmacology·Stephen C HarrisEdward M Sellers
May 6, 2014·Neuropharmacology·Myroslava K RomachEdward M Sellers
Apr 15, 2014·Neuropharmacology·Silvia N Calderon, Michael Klein
Feb 2, 2013·Drug and Alcohol Dependence·Denis G AntoineGeorge E Bigelow
Aug 14, 2018·Journal of Clinical Pharmacology·Sanjeev PathakElliot Ehrich
Sep 1, 2017·PloS One·Erica M SchulteAshley N Gearhardt
Jan 16, 2010·Journal of Clinical Psychopharmacology·Megan J ShramEdward M Sellers
Jun 4, 2010·Clinical Pharmacology and Therapeutics·K A SchoedelE M Sellers
May 3, 2018·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Rachel N CassidyEric C Donny
Mar 15, 2014·CNS Drugs·Hans G CruzJasper Dingemanse
Jun 3, 2016·Journal of Clinical Psychopharmacology·Kerri A SchoedelJohn A Wagner
Sep 20, 2017·Journal of Clinical Psychopharmacology·Kerri A SchoedelEdward M Sellers
Oct 6, 2011·Anaesthesia and Intensive Care·C A HuxtableP E MacIntyre
Mar 18, 2011·Clinical Pharmacology and Therapeutics·M J ShramE M Sellers
Mar 25, 2017·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Lynn WebsterMichael A Eldon
Oct 17, 2019·Frontiers in Psychiatry·Kelly E DunnEric C Strain
Jan 8, 2011·Fundamental & Clinical Pharmacology·Frank RoubyJoëlle Micallef
Oct 22, 2020·Journal of Clinical Psychopharmacology·Megan J ShramKerri A Schoedel